A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.
Clinical trial NCT04469127 · UNKNOWN
Trial details
- NCT number
- NCT04469127
- Sponsor
- Advanced Imaging Projects, LLC
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2025-08-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.